Monday, September 19, 2011

Advanced Cell Technology, Inc. (ACTC) Receives Patent for New Method of Generating Hemangioblast Cells from Human Stem Cells

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today that it has received a patent for technology that can generate and expand hemangioblast cells from human embryonic stem cells. ACT says this technology will use stem cells for the creation of renewable sources of transfuseable blood and platelets to meet the demand for donated blood that can repair damage caused by diseases including diabetes, heart disease, osteoarthritis and multiple sclerosis. ACT has an exclusive license for the commercialization of the technology through a joint venture with South Korean biotechnology company CHA Bio & Diostech Co. Ltd.

The hemangioblast cells are highly expandable and can consistently give rise to cells of the hematopoietic (blood) and endothelial (vascular) lineages. Studies have shown these cells quickly repair vascular damage, thus cutting the death rate after a heart attack in half and restoring the blood flow to limbs that might otherwise be amputated.

“This is the first U.S. patent on the commercial production of hemangioblast cells, and puts another important piece in place for protecting our hemangioblast program and establishing a firm intellectual property position around the therapeutic products we are developing,” stated Gary Rabin, Chairman and Ceo, ACT in a press release on Monday. “We are steadily moving toward the clinic with several cell therapy products that are manufactured from hemangioblasts. Having robust patent protection around our manufacturing process is an integral part of the equation for securing investment in these programs.”

For more information, visit www.advancedcell.com

About QualityStocks:

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net

The Quality Stocks Daily Blog http://blog.qualitystocks.net

The Quality Stocks Daily Videos http://videocharts.qualitystocks.net

The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net

Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net

No comments: